The future landscape of biosimilars in rheumatology: Where we are where we are going.

Abstract:

INTRODUCTION:The upcoming of biosimilars in rheumatic diseases have generated considerable interest throughout the past five years among pharmaceutical industries and regulatory agencies, their development is associated with considerable variation and heterogeneity on the variable requirements for license and marketing throughout the various continents. AIM:In this article we reviewed the contents of the conference presented on the last XI International Conference in Autoimmunity in Lisbon. EVIDENCE:Truly biosimilars that followed requirements from stringent agencies are now available and licensed for infliximab, etanercept, adalimumab and rituximab but several compounds from the same mechanism of action are also being developed and are reviewed and the strengths of their evidence analized and discussed. The use of intended copies (biomimics) and its presence in less regulated markets are also reviewed and the risks of their use without proper monitoring is also evaluated. PLACE IN THERAPY:Biosimilars for rheumatic diseases is expected to change the access of patients to high costs biologics and gradually more and more patients are being switched to biosimilars either by the rheumatologist prescription or mandatory national indications. The economic impact is expected to be huge in the coming years. Second generation biosimilars are also being developed and clinical trials are underway for license in the near future.

journal_name

Autoimmun Rev

journal_title

Autoimmunity reviews

authors

Scheinberg M,Azevedo V

doi

10.1016/j.autrev.2018.09.005

subject

Has Abstract

pub_date

2019-02-01 00:00:00

pages

203-208

issue

2

eissn

1568-9972

issn

1873-0183

pii

S1568-9972(18)30294-5

journal_volume

18

pub_type

杂志文章,评审
  • Efficacy and safety of rituximab in systemic sclerosis: French retrospective study and literature review.

    abstract:OBJECTIVE:To describe safety and efficacy of rituximab in patients with systemic sclerosis. METHODS:We included 13 patients with systemic sclerosis treated with rituximab and pooled with 40 additional patients from the literature. SSc rituximab untreated patients were matched to rituximab treated ones. RESULTS:Thirte...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,meta分析,评审

    doi:10.1016/j.autrev.2017.12.010

    authors: Thiebaut M,Launay D,Rivière S,Mahévas T,Bellakhal S,Hachulla E,Fain O,Mekinian A

    更新日期:2018-06-01 00:00:00

  • Polymyositis, dermatomyositis and malignancy: a further intriguing link.

    abstract::The association between malignancy and autoimmune myositis has been largely described and confirmed by numerous epidemiological studies. The temporal relationship between the two pathologic conditions can vary: malignancy may occur before, at the same time or following the diagnosis of myositis. Beside these observati...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2009.12.005

    authors: Zampieri S,Valente M,Adami N,Biral D,Ghirardello A,Rampudda ME,Vecchiato M,Sarzo G,Corbianco S,Kern H,Carraro U,Bassetto F,Merigliano S,Doria A

    更新日期:2010-04-01 00:00:00

  • The metabolic syndrome: the crossroads between rheumatoid arthritis and cardiovascular risk.

    abstract::Rheumatoid arthritis (RA) patients have an incidence of cardiovascular (CV) diseases at least two times higher than the general population. Atherosclerosis, the main determinant of CV morbidity and mortality, and carotid intima-media thickness, an early preclinical marker of atherosclerosis, also occur early on in RA....

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2011.04.018

    authors: Gremese E,Ferraccioli G

    更新日期:2011-08-01 00:00:00

  • Rett syndrome: An autoimmune disease?

    abstract::Rett syndrome (RTT) is a devastating neurodevelopmental disease, previously included into the autistic spectrum disorders, affecting almost exclusively females (frequency 1:10,000). RTT leads to intellective deficit, purposeful hands use loss and late major motor impairment besides featuring breathing disorders, epile...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2016.01.011

    authors: De Felice C,Leoncini S,Signorini C,Cortelazzo A,Rovero P,Durand T,Ciccoli L,Papini AM,Hayek J

    更新日期:2016-04-01 00:00:00

  • The role of innate immune responses in autoimmune disease development.

    abstract::Autoimmune diseases are systemic or organ-specific disorders that are the result of an attack of the immune system against the body's own tissue. Development of autoimmune disease is generally avoided by distinct mechanisms that silence adaptive self-reactive T or B cells. The innate immune system is critically involv...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2008.12.019

    authors: Waldner H

    更新日期:2009-03-01 00:00:00

  • Myocarditis in auto-immune or auto-inflammatory diseases.

    abstract::Myocarditis is a major cause of heart disease in young patients and a common precursor of heart failure due to dilated cardiomyopathy. Some auto-immune and/or auto-inflammatory diseases may be accompanied by myocarditis, such as sarcoidosis, Behçet's disease, eosinophilic granulomatosis with polyangiitis, myositis, an...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2017.05.021

    authors: Comarmond C,Cacoub P

    更新日期:2017-08-01 00:00:00

  • Hashimoto thyroiditis: clinical and diagnostic criteria.

    abstract::Hashimoto thyroiditis (HT), now considered the most common autoimmune disease, was described over a century ago as a pronounced lymphoid goiter affecting predominantly women. In addition to this classic form, several other clinico-pathologic entities are now included under the term HT: fibrous variant, IgG4-related va...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2014.01.007

    authors: Caturegli P,De Remigis A,Rose NR

    更新日期:2014-04-01 00:00:00

  • Mechanistic immunological based classification of rheumatoid arthritis.

    abstract::The classical autoimmunity paradigm in rheumatoid arthritis (RA) is strongly supported by immunogenetics suggesting follicular helper T-cell responses driving high titre specific autoantibodies that pre-dates disease onset. Using the immunological disease continuum model of inflammation against self with "pure" adapti...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2018.06.001

    authors: McGonagle D,Watad A,Savic S

    更新日期:2018-11-01 00:00:00

  • Coronary involvement in Takayasu's arteritis.

    abstract::Coronary involvement may appear in up to a third of patients with Takayasu's arteritis. This affliction may have a dominant impact on the clinical manifestations of the patient. Occlusion of the ostia of the left main coronary artery and of proximal segments of the coronary arteries is the most frequent finding of the...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2007.04.001

    authors: Rav-Acha M,Plot L,Peled N,Amital H

    更新日期:2007-09-01 00:00:00

  • New use for an old treatment: Hydroxychloroquine as a potential treatment for systemic vasculitis.

    abstract::Antimalarials have been an effective and safe treatment for autoimmune rheumatic diseases such as systemic lupus erythematosus for more than a hundred years. There are surprisingly few reports of hydroxychloroquine use in the systemic vasculitides. Hydroxychloroquine has antithrombotic, cardiovascular, antimicrobial a...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2018.01.016

    authors: Casian A,Sangle SR,D'Cruz DP

    更新日期:2018-07-01 00:00:00

  • Influenza and pneumococcal vaccinations of patients with systemic lupus erythematosus: current views upon safety and immunogenicity.

    abstract::Systemic lupus erythematosus (SLE) is a chronic immune-mediated inflammatory multisystem disease. The onset of viral and bacterial infections may favor the exacerbation of the disease, amplify autoimmune processes and contribute to mortality and morbidity. The prevention of influenza and Streptococcus pneumoniae infec...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2013.07.007

    authors: Murdaca G,Orsi A,Spanò F,Puppo F,Durando P,Icardi G,Ansaldi F

    更新日期:2014-02-01 00:00:00

  • Kinin receptors: Key regulators of autoimmunity.

    abstract::The central function of the immune system is to protect the host from environmental agents such as microbes or chemicals, thereby preserving the integrity of the body, and preventing the onset of illness and infection. Moreover, the immune system is constantly challenged to discriminate self vs. non-self and mediate t...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2016.12.011

    authors: Dutra RC

    更新日期:2017-02-01 00:00:00

  • Description of 214 cases of autoimmune congenital heart block: Results of the French neonatal lupus syndrome.

    abstract:BACKGROUND:Cardiac neonatal lupus syndrome is due to anti-SSA or SSB antibodies and mainly includes congenital heart block (CHB) and dilated cardiomyopathy (DCM). Its optimal management is still debated. We report a large series of autoimmune high degree CHB. METHODS:Inclusion criteria in this retrospective study were...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2015.08.005

    authors: Levesque K,Morel N,Maltret A,Baron G,Masseau A,Orquevaux P,Piette JC,Barriere F,Le Bidois J,Fermont L,Fain O,Theulin A,Sassolas F,Pezard P,Amoura Z,Guettrot-Imbert G,Le Mercier D,Georgin-Lavialle S,Deligny C,Hachull

    更新日期:2015-12-01 00:00:00

  • Polyarteritis nodosa: A contemporary overview.

    abstract::Polyarteritis nodosa (PAN) is a systemic necrotizing vasculitis predominantly targeting medium-sized arteries. PAN is a rare form of vasculitis, and the precise frequency of this disease is difficult to determine. The major environmental factor associated with PAN is HBV infection. The pathogenesis of "idiopathic PAN"...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2016.02.015

    authors: De Virgilio A,Greco A,Magliulo G,Gallo A,Ruoppolo G,Conte M,Martellucci S,de Vincentiis M

    更新日期:2016-06-01 00:00:00

  • Incidence and nature of infectious disease in patients treated with anti-TNF agents.

    abstract::Tumor necrosis factor alpha (TNF-alpha) inhibitors offer a targeted therapeutic strategy that contrasts with the nonspecific immunosuppressive agents traditionally used to treat most inflammatory diseases. These biologic agents have had a significant impact in ameliorating the signs and symptoms of inflammatory rheuma...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2009.08.006

    authors: Raychaudhuri SP,Nguyen CT,Raychaudhuri SK,Gershwin ME

    更新日期:2009-12-01 00:00:00

  • The geoepidemiology of autoimmune intestinal diseases.

    abstract::Inflammatory bowel diseases (IBD) are chronic diseases of the intestinal tract which principally are composed of ulcerative colitis (UC) and Crohn's disease (CD). The prevalence and incidence of both forms of IBD have historically been higher in developed countries with decreasing North-South gradient. However, more r...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2009.11.008

    authors: Logan I,Bowlus CL

    更新日期:2010-03-01 00:00:00

  • Rheumatoid arthritis (RA) and cardiovascular disease.

    abstract::Patients with rheumatoid arthritis (RA) suffer cardiovascular events 1.5-2 fold than the general population, and cardiovascular (CV) events are leading cause of death in patients with RA. It is known that patients with RA have endothelial dysfunction, related with impaired function of endothelial progenitor cells (EPC...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,收录出版,评审

    doi:10.1016/j.autrev.2019.05.005

    authors: Blum A,Adawi M

    更新日期:2019-07-01 00:00:00

  • Importance of the dense fine speckled pattern on HEp-2 cells and anti-DFS70 antibodies for the diagnosis of systemic autoimmune diseases.

    abstract::The presence of anti-nuclear antibodies (ANA) is a hallmark of systemic autoimmune rheumatic diseases (SARD). The indirect immunofluorescence (IIF) assay on HEp-2 cells is a commonly used test for the detection of ANA and was recently recommended as the screening test of choice by a task force of the American College ...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2011.11.005

    authors: Mahler M,Hanly JG,Fritzler MJ

    更新日期:2012-07-01 00:00:00

  • Multiple sclerosis: geoepidemiology, genetics and the environment.

    abstract::Multiple sclerosis (MS) is a chronic immune-mediated demyelinating disease of the central nervous system characterized by relapses and remissions. The risk of acquiring this complex disease is associated with exposure to environmental factors in genetically susceptible individuals. The epidemiology of MS has been exte...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2009.11.010

    authors: Milo R,Kahana E

    更新日期:2010-03-01 00:00:00

  • Hyperhomocysteinemia, inflammation and autoimmunity.

    abstract::Hyperhomocysteinemia is independently associated with the development of coronary, cerebral and peripheral vascular disease and deep-vein thrombosis in the general population. The evidence that cardiovascular involvement is particularly frequent and advanced in patients affected with several autoimmune diseases (AD), ...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2007.03.008

    authors: Lazzerini PE,Capecchi PL,Selvi E,Lorenzini S,Bisogno S,Galeazzi M,Laghi Pasini F

    更新日期:2007-08-01 00:00:00

  • Epidemiological and ethical aspects of multiplex autoantibody testing.

    abstract::Arrays are one of the technologies able to detect autoantibodies by measuring simultaneously many thousands of markers from a unique biological sample. The main purpose of a diagnostic test is making an early and accurate diagnosis. From a statistical point of view, multiple testing increases the probability of false ...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2007.01.008

    authors: Bidoli E,Villalta D,Ethical Committee of Pordenone Hospital, Italy.,Battistin M,Bidoli E,Cammarota A,Ciccone M,Fedato R,Lodi B,Marchesini F,Molaro G,Ostardo E,Rellini G,Sartori R,Schinella D

    更新日期:2007-06-01 00:00:00

  • 14th International Congress on Antiphospholipid Antibodies Task Force Report on Catastrophic Antiphospholipid Syndrome.

    abstract::The 'Task Force on Catastrophic Antiphospholipid Syndrome (CAPS)' was developed on the occasion of the 14th International Congress on Antiphospholipid Antibodies. The objectives of this Task Force were to assess the current knowledge on pathogenesis, clinical and laboratory features, diagnosis and classification, prec...

    journal_title:Autoimmunity reviews

    pub_type:

    doi:10.1016/j.autrev.2014.03.002

    authors: Cervera R,Rodríguez-Pintó I,Colafrancesco S,Conti F,Valesini G,Rosário C,Agmon-Levin N,Shoenfeld Y,Ferrão C,Faria R,Vasconcelos C,Signorelli F,Espinosa G

    更新日期:2014-07-01 00:00:00

  • Anti-neuronal antibodies in patients with HCV-related mixed cryoglobulinemia.

    abstract::Mixed cryoglobulinemia (MC) is an immunological disorder characterized by immune-complex-mediated systemic vasculitis involving small vessels, which may present with renal, cutaneous, rheumatologic, and/or neurological manifestations. Until recently, the possible appearance of anti-neuronal autoantibodies in periphera...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2008.07.027

    authors: Alpa M,Ferrero B,Cavallo R,Naretto C,Menegatti E,Di Simone D,Napoli F,La Grotta R,Rossi D,Baldovino S,Sena LM,Roccatello D

    更新日期:2008-10-01 00:00:00

  • Autotaxin, Pruritus and Primary Biliary Cholangitis (PBC).

    abstract::Autotaxin (ATX) is a 125-kD type II ectonucleotide pyrophosphatase/phosphodiesterase (ENPP2 or NPP2) originally discovered as an unknown "autocrine motility factor" in human melanoma cells. In addition to its pyrophosphatase/phosphodiesterase activities ATX has lysophospholipase D (lysoPLD) activity, catalyzing the co...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2016.03.019

    authors: Sun Y,Zhang W,Evans JF,Floreani A,Zou Z,Nishio Y,Qi R,Leung PS,Bowlus CL,Gershwin ME

    更新日期:2016-08-01 00:00:00

  • Spanish scleroderma risk score (RESCLESCORE) to predict 15-year all-cause mortality in scleroderma patients at the time of diagnosis based on the RESCLE cohort: Derivation and internal validation.

    abstract::A few scores predicting the short-term risk of mortality in Systemic sclerosis (SSc) have been reported to date. Our study aimed to create a predictive 15-year all-cause mortality score at the time of the diagnosis of SSc. The study was based on the Spanish Scleroderma Registry (RESCLE). The cohort was split up in der...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章

    doi:10.1016/j.autrev.2020.102507

    authors: Rubio-Rivas M,Corbella X,Guillén-Del-Castillo A,Tolosa Vilella C,Colunga Argüelles D,Argibay A,Vargas Hitos JA,Todolí Parra JA,González-Echávarri C,Ortego-Centeno N,Trapiella Martínez L,Rodríguez Carballeira M,Marín Ballvé A,Pl

    更新日期:2020-05-01 00:00:00

  • Rituximab for the treatment of eosinophilic granulomatosis with polyangiitis: A systematic literature review.

    abstract:OBJECTIVE:We investigated the effectiveness of rituximab (an anti-CD20 monoclonal antibody) in patients with eosinophilic granulomatosis with polyangiitis (EGPA). METHODS:We performed a systematic literature review from the inception dates until July 20, 2020 for articles reporting rituximab administration to treat EG...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2020.102737

    authors: Akiyama M,Kaneko Y,Takeuchi T

    更新日期:2021-02-01 00:00:00

  • Environmental and occupational stress and autoimmunity.

    abstract::The immune system and the neuroendocrine system machinery modulate each other, including life events-induced stresses and interpersonal conflicts, promoting the synthesis of proinflammatory cytokines, overproduction of which influence behaviour. In addition, the balance of systemic and local pro-inflammatory cytokines...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2007.12.003

    authors: Boscolo P,Youinou P,Theoharides TC,Cerulli G,Conti P

    更新日期:2008-02-01 00:00:00

  • Generalized mathematical model for immunoassay interference.

    abstract::As part of a landmark review of the antigen excess, Jacobs et al. (Autoimmunity Reviews 2015;14:160-167) contrast how immunoassay "interference" by non-target biomolecules can cause spurious readings for clinical diagnostic tests. The purpose of the present Letter is to complement and analytically extend this descript...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2020.102663

    authors: Holmes TH

    更新日期:2020-11-01 00:00:00

  • Vitamin D and systemic lupus erythematosus - The hype and the hope.

    abstract::Over the past 20years, much has been written about the potential role of vitamin D in on adverse health outcomes. In recent years, evidence has accumulated regarding the effect of vitamin D on the immune system, and its different cells. Some studies have noted lower vitamin D concentrations in patients with SLE. These...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2017.11.004

    authors: Shoenfeld Y,Giacomelli R,Azrielant S,Berardicurti O,Reynolds JA,Bruce IN

    更新日期:2018-01-01 00:00:00

  • Anti-CD 20 monoclonal antibody (rituximab) treatment for inflammatory ocular diseases.

    abstract::Rituximab is a monoclonal antibody directed against the CD20 antigen expressed on B cells and widely used in the treatment of non-Hodgkin's lymphoma and rheumatoid arthritis. There is a growing amount of literature which suggests that rituximab may be useful for inflammatory ocular diseases and intraocular lymphoma. F...

    journal_title:Autoimmunity reviews

    pub_type: 杂志文章,评审

    doi:10.1016/j.autrev.2011.07.001

    authors: Miserocchi E,Pontikaki I,Modorati G,Gattinara M,Meroni PL,Gerloni V

    更新日期:2011-11-01 00:00:00